Diabetes Drug Could Slow the Progression of PD
- Ghosh A, et al. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson’s disease. Science Translational Medicine. 2016. http://stm.sciencemag.org/content/8/368/368ra174.full">http://stm.sciencemag.org/content/8/368/368ra174.full. Accessed April 1, 2017.
- Sumter, Angelica. Type 2 Diabetes drug could slow Parkinson’s disease progression, human trials to begin next year, say researchers. Inquisitr. Dec 2016. http://www.inquisitr.com/3785742/type-2-diabetes-drug-could-slow-parkinsons-disease-progression-human-trials-to-begin-next-year-says-researchers/. Accessed April 1, 2017.
- Drain, Kelsey. Parkinson’s disease cure update: Diabetes drug that may slow progression is being readied for trials. Medical Daily. 2016. http://www.medicaldaily.com/parkinsons-disease-cure-update-diabetes-drug-may-slow-progression-being-406200. Accessed April 1, 2017.